Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
114.46B | 113.51B | 107.85B | 98.15B | 218.35B | 283.47B | Gross Profit |
56.92B | 55.63B | 53.44B | 48.29B | 49.45B | 65.74B | EBIT |
4.32B | 3.90B | 1.57B | -1.40B | -2.02B | 4.53B | EBITDA |
8.73B | 9.63B | 7.51B | 5.26B | 3.02B | 10.51B | Net Income Common Stockholders |
2.96B | 2.78B | 1.89B | -775.00M | -4.95B | 3.23B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
3.69B | 3.73B | 3.24B | 4.10B | 5.62B | 3.45B | Total Assets |
119.93B | 115.36B | 118.34B | 119.38B | 123.42B | 130.51B | Total Debt |
4.51B | 6.04B | 12.58B | 16.84B | 17.22B | 14.69B | Net Debt |
824.00M | 2.31B | 9.34B | 12.74B | 11.60B | 11.24B | Total Liabilities |
83.81B | 78.05B | 83.76B | 86.07B | 89.78B | 91.67B | Stockholders Equity |
36.11B | 37.32B | 34.59B | 33.31B | 33.64B | 38.84B |
Cash Flow | Free Cash Flow | ||||
0.00 | 6.59B | 4.67B | -1.12B | 146.00M | 2.77B | Operating Cash Flow |
0.00 | 10.17B | 7.56B | 2.50B | 4.30B | 10.00B | Investing Cash Flow |
0.00 | -2.19B | -3.02B | -3.30B | -3.61B | -6.92B | Financing Cash Flow |
0.00 | -7.49B | -5.40B | -715.00M | 1.48B | -3.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥526.35B | 12.54 | 10.29% | 2.80% | 8.57% | 40.46% | |
74 Outperform | $334.38B | 8.69 | 8.38% | 2.10% | 6.94% | 26.27% | |
73 Outperform | $799.68B | 15.38 | 8.71% | 2.34% | 3.56% | -2.39% | |
70 Neutral | €233.11B | 6.47 | 11.92% | 2.27% | 3.71% | 62.31% | |
68 Neutral | ¥56.99B | 23.91 | 1.12% | 16.65% | -9.43% | ||
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
55 Neutral | ¥72.07B | 20.32 | 1.12% | 1.41% | 27.48% |